CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One

CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One

Objective: To study whether cerebrospinal fluid (CSF) analysis may serve as a diagnostic test for the screening of epilepsy in sporadic prodromal Alzheimer's disease (AD).Methods: A total of 29 patients with epileptic prodromal sporadic AD patients (epADs) were included and were retrospectively...

Full description

Bibliographic Details
Main Authors: Benjamin Cretin, Olivier Bousiges, Geoffroy Hautecloque, Nathalie Philippi, Frederic Blanc, Laure Dibitonto, Catherine Martin-Hunyadi, François Sellal
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Neurology
Subjects:
Alzheimer's disease
late onset epilepsy
mild cognitive impairment
cerebrospinal fluid
small vessel disease
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.623777/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.623777/full

Similar Items